In:
Clinical and Experimental Dermatology, Oxford University Press (OUP), Vol. 48, No. 9 ( 2023-08-25), p. 1048-1050
Abstract:
The management of actinic keratoses and field cancerization is a therapeutic challenge. Tirbanibulin 1% ointment is a promising new drug for use on specific parts of the body or in patients who are refractory or reluctant to use other more aggressive treatments.
Type of Medium:
Online Resource
ISSN:
0307-6938
,
1365-2230
Language:
English
Publisher:
Oxford University Press (OUP)
Publication Date:
2023
detail.hit.zdb_id:
2004506-2
Permalink